AHZ.AX - Admedus Limited

ASX - ASX Delayed price. Currency in AUD
+0.0030 (+4.48%)
At close: 3:59PM AEDT
Stock chart is not supported by your current browser
Previous close0.0670
Bid0.0700 x 0
Ask0.0710 x 0
Day's range0.0670 - 0.0740
52-week range0.0560 - 0.0840
Avg. volume405,785
Market cap41.988M
Beta (3Y monthly)0.07
PE ratio (TTM)N/A
EPS (TTM)-0.0530
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Is Admedus Limited (ASX:AHZ) Overpaying Its CEO?
    Simply Wall St.

    Is Admedus Limited (ASX:AHZ) Overpaying Its CEO?

    Wayne Paterson became the CEO of Admedus Limited (ASX:AHZ) in 2017. First, this article will compare CEO compensation...

  • GlobeNewswire

    LeMaitre Vascular Acquires Biologic Patch Business from Admedus

    The acquired patches, marketed under the brands CardioCel® and VascuCel®, are processed in a manner that is intended to reduce the risk of calcification.  Annualized 2019 sales of these product lines were $7.1 million, mostly in the US and Europe. Guidance on how this acquisition may affect LeMaitre Vascular’s 2019 revenue, operating income and EPS expectations will be provided at the Company’s Q3 2019 earnings call on October 23, 2019.

  • How Many Insiders Bought Admedus Limited (ASX:AHZ) Shares?
    Simply Wall St.

    How Many Insiders Bought Admedus Limited (ASX:AHZ) Shares?

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! We often see insiders buying up shares in companies thatRead More...